1 results found

Riya Albert, Joshua Thomas, Navid Sadeghi, Sangeetha Reddy, Glenda Delgado, Heather McArthur, Samira Syed, Deborah Farr, Nisha Unni

Introduction Triple-negative breast cancer (TNBC) is an aggressive subtype characterized by poor prognosis. Based on the KEYNOTE-522 trial, neoadjuvant pembrolizumab plus chemotherapy has become the s...

Breast Cancer Research and Treatment 2026-04-21 rs-9096569
tumor-infiltrating lymphocytes triple-negative breast cancer neoadjuvant therapy immunotherapy pathological complete response
Back to Top
Home
Browse
Submit
About
0.048498s